Allergan Deal Gets Compounder To Say Drugs Not FDA-OK’d

By Dani Kass

Law360 (February 1, 2019, 4:44 PM EST) — Allergan Inc.’s aggressive bid to block sales of lower-cost compounded drugs has ended with a compounder’s agreement to tell customers that its products aren’t approved by the U.S. Food and Drug…